Business Description
Skye Bioscience Inc
NAICS : 325412
SIC : 2834
ISIN : US64046J1007
Share Class Description:
SKYE: Ordinary SharesDescription
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | -0.18 | |||||
| Debt-to-Equity | -2.17 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 6.1 | |||||
| 3-Year EPS without NRI Growth Rate | 28.1 | |||||
| 3-Year FCF Growth Rate | 32.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.69 | |||||
| 9-Day RSI | 44.49 | |||||
| 14-Day RSI | 48.52 | |||||
| 6-1 Month Momentum % | 793.71 | |||||
| 12-1 Month Momentum % | 370.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.84 | |||||
| Quick Ratio | 0.84 | |||||
| Cash Ratio | 0.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -120.5 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -432.93 | |||||
| ROIC % | -148.56 | |||||
| ROC (Joel Greenblatt) % | -9209.98 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -9.98 | |||||
| EV-to-EBITDA | -10.01 | |||||
| EV-to-FCF | -26.22 | |||||
| Earnings Yield (Greenblatt) % | -10.02 | |||||
| FCF Yield % | -3.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SKYE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Skye Bioscience Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -6.829 | ||
| Beta | 2.78 | ||
| Volatility % | 283.38 | ||
| 14-Day RSI | 48.52 | ||
| 14-Day ATR ($) | 1.65108 | ||
| 20-Day SMA ($) | 13.194 | ||
| 12-1 Month Momentum % | 370.38 | ||
| 52-Week Range ($) | 1.44 - 19.4099 | ||
| Shares Outstanding (Mil) | 28.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Skye Bioscience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Skye Bioscience Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Skye Bioscience Inc Frequently Asked Questions
What is Skye Bioscience Inc(SKYE)'s stock price today?
The current price of SKYE is $12.96. The 52 week high of SKYE is $19.41 and 52 week low is $1.44.
When is next earnings date of Skye Bioscience Inc(SKYE)?
The next earnings date of Skye Bioscience Inc(SKYE) is 2024-05-08.
Does Skye Bioscience Inc(SKYE) pay dividends? If so, how much?
Skye Bioscience Inc(SKYE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers